Sign in

Asya Minervina

@asya-minervina.bsky.social
250 followers 98 following 1 posts
PostsRepliesMedia
Asya Minervina @asya-minervina.bsky.social · 04/09/2026
Our paper is out! It turns out that finding the right TCR partner is a bit like matching socks🧦: almost every pair fits, but only a small fraction make the right match for antigen recognition. If you don’t feel like diving into the full paper, there’s also a one-page summary!
083
Reposted by Asya Minervina
Paul Thomas @pgtimmune.bsky.social · 04/09/2026
TCR specificity prediction is advancing rapidly. The central question is not only which TCR sequence recognizes an antigen, but also which TCR pairings make recognition possible & where is the binding boundary? Our new paper tackles these questions. 🧵 www.science.org/doi/10.1126/...
science.org
Uneven TCR chain pairing constraints govern epitope recognition
Combinatorial pairing of independently recombined T cell receptor (TCR) α- and β-chains is central to diversifying the TCR repertoire. Although sequence motifs in one chain correlate with epitope reco...
22210
Reposted by Asya Minervina
William DeWitt @wsdewitt.github.io · 05/06/2026
This started in 2019 as daydreamy PhD student musings with Tatsuya Araki. We're as excited as ever about germinal centers as a platform for experimental evolution. Many thanks to PIs @victora.bsky.social @matsen.bsky.social, co-1st authors Ashni Vora and Tatsuya, and many other key collaborators!
cell.com
Replaying germinal center evolution on a quantified affinity landscape
Antibody affinity maturation results from a somatic evolutionary process that takes place in the germinal center. A “parallel replay” experiment on germinal center B cells reveals the evolutionary for...
24319
Reposted by Asya Minervina
Prof. Shane Crotty @profshanecrotty.bsky.social · 14/04/2026
My new comprehensive review of Immune Memory to Vaccines is out! It has an emphasis on human vaccines. It is also accompanied by a full video lecture. Enjoy! @lji.org @cp-immunity.bsky.social authors.elsevier.com/sd/article/S...
authors.elsevier.com
ScienceDirect.com | Science, health and medical journals, full text articles and books.
13913
Reposted by Asya Minervina
Rob Mettelman @rmettelman.bsky.social · 04/03/2026
The Mettelman Lab at the University of Pittsburgh Center for Vaccine Research has officially opened its doors, and I’m looking to hire a Lab Manager! If interested, please apply using the link below Come join our team of 1! cfopitt.taleo.net/careersectio...
cfopitt.taleo.net
Laboratory Manager
Click the link provided to see the complete job description.
053
Reposted by Asya Minervina
Immunity @cp-immunity.bsky.social · 28/01/2026
Online now: Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo
dlvr.it
Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo
Mapping TCRs to antigens at scale presents a major challenge. Gaglione et al. develop an approach to rapidly synthesize and screen thousands of TCRs, enabling broad TCR-antigen screening. Examining T cell specificity in vitiligo uncovers autoreactive T cells with transcriptional programs similar to melanoma-reactive T cells, revealing shared features of disease-relevant T cells in autoimmunity and cancer.
053
Reposted by Asya Minervina
Paul Thomas @pgtimmune.bsky.social · 24/11/2025
Two complementary studies from our group out today: a therapeutic peptide vaccine trial for fibrolamellar carcinoma (FLC) & TIRTL-Seq, our robust method for deep quantitative paired TCR sequencing a🧵w/ @markyarchoan.bsky.social & @pogorely.bsky.social www.nature.com/articles/s41...
nature.com
TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing - Nature Methods
TIRTL-seq is a high-throughput method for paired T cell receptor sequencing at the cohort scale.
43413
Reposted by Asya Minervina
Fred Hutch @fredhutch.org · 07/11/2025
Viral immunologist @pgtimmune.bsky.social, who recently joined Fred Hutch's Vaccine and Infectious Diseases Division, aims to harness the "incredible potential" of the immune system to advance diagnostics, vaccines and cancer therapies. bit.ly/3WJVpos
bit.ly
Viral immunologist taps ‘incredible potential’ of immune system
New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune system into real-life diagnostic and therapeutic applications. He studies ho...
0238
Reposted by Asya Minervina
Armita Nourmohammad @thearmita.bsky.social · 27/10/2025
excited to announce that this January we are relocating to Yale to start a theory initiative at the Center for Systems and Engineering Immunology (CSEI): @yalecsei.bsky.social looking to hire 2 postdocs to join us in this endeavor. more details can be found here: sites.google.com/uw.edu/statp...
sites.google.com
SPE - join us
Postdoctoral position: In January 2026, we are relocating to Yale university to start a theory initiative at the Center for Systems and Engineering Immunology (CSEI). We are looking for talented postd...
1218
Reposted by Asya Minervina
Armita Nourmohammad @thearmita.bsky.social · 16/10/2025
excited that this paper is finally out in @pnas.org : www.pnas.org/doi/10.1073/... Led by Gian Marco Visani (effort initiated by Michael Pun), fantastic collaboration with @pgtimmune.bsky.social @asya-minervina.bsky.social and Phil Bradley.
pnas.org
T cell receptor specificity landscape revealed through de novo peptide design | PNAS
T cells play a key role in adaptive immunity by mounting specific responses against diverse pathogens. Effective bindings between T cell receptors ...
0169
Reposted by Asya Minervina
Kilian Schober @kischober.bsky.social · 03/10/2025
If the immune system is an army... ... would you rather rely on one “super warrior” — or on a diverse team of fighters, even if none of them is the single strongest? I’d go with the team. Why? Check out our new study, just published in Science Immunology: www.science.org/doi/10.1126/...
57321
Reposted by Asya Minervina
Prof. Shane Crotty @profshanecrotty.bsky.social · 30/07/2025
After 30+ years of HIV vaccine clinical trials, this is the first time that neutralizing antibodies against an HIV clinical isolate has been generated in vaccinated people. * "Tier 2" neutralizing antibodies, induced consistently. www.science.org/doi/10.1126/... www.science.org/doi/10.1126/...
science.org
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models
An HIV envelope trimer mRNA vaccine enables membrane-bound expression and produces a functional immunogen in preclinical mammalian models.
35115
Reposted by Asya Minervina
Paul Thomas @pgtimmune.bsky.social · 15/07/2025
How much of the TCR repertoire can we make sense of? Can your TCR and GEX data be put in the context of other conditions/tissues? How many varieties of T cells are in the repertoire zoo? All these questions (& more) addressed in our latest preprint: MetaCoNGA www.biorxiv.org/content/10.1... . a 🧵
biorxiv.org
Diverse modes of T cell receptor sequence convergence define unique functional and cellular phenotypes
Single-cell techniques allow concurrent study of gene activity and T cell receptor (TCR) sequences, identifying connections between TCR structure and cell traits. Expanding on our CoNGA software, we p...
12910
Reposted by Asya Minervina
Gabriel Victora @victora.bsky.social · 05/06/2025
Wanted to highlight our latest preprint--a huge effort by multiple people and labs, but led primarily by @wsdewitt.github.io, Tatsuya Araki, and Ashni Vora, in a very close wet-dry collaboration with @matsen.bsky.social’s lab at the Hutch www.biorxiv.org/content/10.1...
biorxiv.org
Replaying germinal center evolution on a quantified affinity landscape
Darwinian evolution of immunoglobulin genes within germinal centers (GC) underlies the progressive increase in antibody affinity following antigen exposure. Whereas the mechanics of how competition be...
16728
Reposted by Asya Minervina
Damon May @the-dee-em.bsky.social · 19/03/2025
The recent "Mal-ID" paper in Science diagnoses diseases from immune repertoires. But a powerful model like Mal-ID can learn differences between groups of immune repertoires that are unrelated to the diseases of interest. We explore these pitfalls in our eLetter response.
science.org
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Clinical diagnosis typically incorporates physical examination, patient history, various laboratory tests, and imaging studies but makes limited use of the human immune system’s own record of antigen ...
0207
Reposted by Asya Minervina
Jamie Heather @jamieheather.bsky.social · 25/02/2025
Dear TCR researchers of #immunosky, you may be interested to know that our tool Stitchr - for the automated production of full-length T cell receptor sequences - has just had a nice little update: jamieheather.github.io/stitchr/
jamieheather.github.io
stitchr — stitchr documentation
2367
Reposted by Asya Minervina
Nicole La Gruta @niclag.bsky.social · 21/02/2025
Our paper is out! LCK–co-receptor association ensures T cell lineage fidelity and maximizes epitope-specific TCR diversity | Science Immunology www.science.org/doi/10.1126/...
science.org
LCK–co-receptor association ensures T cell lineage fidelity and maximizes epitope-specific TCR diversity
LCK-mutant mice help define the role of LCK–co-receptor association in T cell development and immune responses.
43510
Reposted by Asya Minervina
Richard Neher @neher.io · 11/01/2025
Building on the UShER tree of millions of SARS-CoV-2 genomes maintained by Angie Hinrichs, Hugh Haddox and Georg Angehrn (and others in @matsen.bsky.social lab and @jbloomlab.bsky.social) have looked into how the neutral mutation rate varies along the genome: [1/N] www.biorxiv.org/content/10.1...
biorxiv.org
The mutation rate of SARS-CoV-2 is highly variable between sites and is influenced by sequence context, genomic region, and RNA structure
RNA viruses like SARS-CoV-2 have a high mutation rate, which contributes to their rapid evolution. The rate of mutations depends on the mutation type (e.g., A→C, A→G, etc.) and can vary between sites ...
14819
Reposted by Asya Minervina
Jennifer Juno @jenjuno.viralvaxlab.com · 20/12/2024
9/9 Thanks to all our collaborators who helped out with the study, and congrats to Mitchell, who persevered through a lot of possible activation marker combinations!
041
Reposted by Asya Minervina
Q-Immuno lab at UCL @qimmuno.bsky.social · 19/12/2024
How to learn generalizable rules across complex sequence-function maps? 💡In our new preprint we propose a framework for learning two-point statistics and use it to discover biophysical rules of TCR co-specificity that generalize to unseen ligands ! ✨ arxiv.org/abs/2412.13722
Intuition behind why two-point statistics might provide an easier path to generalization
095
Reposted by Asya Minervina
Paul Thomas @pgtimmune.bsky.social · 26/11/2024
ALSO! We are hiring for the last open position (Bioinformatics Research Scientist) in the TIRTL group! Love coding, math, robotics, and uncovering the immune system's secrets? You know you do, so join us! (stjude.wd1.myworkdayjobs.com/stjude/job/M...).
stjude.wd1.myworkdayjobs.com
Bioinformatics Research Scientist (TIRTL Bluesky)
The Bioinformatics Research Scientist is responsible for designing, developing, improving, modifying, and operating data analysis pipelines. Manages projects and coordinates other efforts related to a...
11511
Reposted by Asya Minervina
Sander Wuyts, PhD 🧬 @swuyts.bsky.social · 21/11/2024
Calling all T-cell aficionado's. Come and join us next year (27-28 May 2025) for the fourth Antwerp T-Cell Receptor conference organised by @pmeysman.bsky.social, @krislaukens.bsky.social and Benson Ogunjimi. I'll also be there! www.uantwerpen.be/en/conferenc... #ImmunoSky
12512
Reposted by Asya Minervina
Pallett Lab UCL @pallettlab.bsky.social · 19/11/2024
We’ve jumped on board fully here on 🦋 A starter pack of those working on our favourite cell … the T cell 🥰🙈🥰 If you want an add let us know go.bsky.app/8B5P25c
467426
Reposted by Asya Minervina
Rod Rahimi @rodrahimi.bsky.social · 19/11/2024
Friends, the second #immunology starter pack filled in 3 days! I started a third to help folks new to BlueSky rebuild their network Below are the links If you're an immunologist and I have missed you so far, let me know 🧪 go.bsky.app/PY5tCas go.bsky.app/FmERUoD go.bsky.app/6aT6qDS
9013270
Reposted by Asya Minervina
Andrew Oberst @drewoberst.bsky.social · 18/11/2024
OK, #immunology Bluesky LFG! If, like me, you're trying to reconstruct the vibrant scientific network we had at the other place, these starter packs are a great start: go.bsky.app/2bqX3T7 go.bsky.app/PY5tCas go.bsky.app/FmERUoD go.bsky.app/AjNpW2h go.bsky.app/SinqoJU go.bsky.app/DmphBCT
66222
Reposted by Asya Minervina
Jamie Heather @jamieheather.bsky.social · 18/11/2024
Inspired by @rodrahimi.bsky.social 's noble efforts linking immunologists together over here, let's try and get more specifically TCR/BCR/AIRR/repertoire chat going with this starter park go.bsky.app/Gi2dcGd Drop me a beep to get added or suggest others!
217029